The oxidative potential of differently charged silver and gold nanoparticles on three human lung epithelial cell types

Journal of Nanobiotechnology

Volumn 13, Issue 1, 2015, Pages

  Schlinkert, Paul ^a   Casals, Eudald ^b   Boyles, Matthew ^a   Tischler, Ulrike ^a   Hornig, Eva ^a   Tran, Ngoc ^b   Zhao, Jiayuan ^c   Himly, Martin ^a   Riediker, Michael ^c,d   Oostingh, Gertie Janneke ^a,e   Puntes, Victor ^b   Duschl, Albert ^a  

^a UNIVERSITY OF SALZBURG   (Austria)

^b CATALAN INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY ICN2   (Spain)

^c Pôle Santeacute des Travailleurs   (Switzerland)

^d Institue for Occupational Medicine (IOM) Singapore   (Singapore)

^e SALZBURG UNIVERSITY OF APPLIED SCIENCES   (Austria)

Author keywords

Cytotoxicity; Human lung epithelial cells; Nanoparticles; ROS production; Surface charge

Indexed keywords

BIOLOGICAL ORGANS; CELL CULTURE; CHITIN; CHITOSAN; COATINGS; COREMAKING; CYTOLOGY; CYTOTOXICITY; GOLD; GOLD ALLOYS; MOBILE SECURITY; MULTILAYERS; NANOPARTICLES; RESPIRATORY SYSTEM; SILVER; SURFACE CHARGE; TOXICITY;

CELLULAR TOXICITIES; GROWTH CHARACTERISTIC; HUMAN LUNG; IMMUNOFLUORESCENCE STAINING; LACTATE DEHYDROGENASE ASSAYS; LUNG EPITHELIAL CELLS; REACTIVE OXYGEN SPECIES; SILVER AND GOLD NANOPARTICLES;

CELLS;

CHITOSAN; CITRATE SODIUM; GOLD NANOPARTICLE; LACTATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; SILVER NANOPARTICLE; CULTURE MEDIUM; GOLD; METAL NANOPARTICLE; OXIDIZING AGENT; SILVER;

A549 CELL LINE; ARTICLE; BEAS 2B CELL; CELL DAMAGE; CELL DENSITY; CELL FREE SYSTEM; CELL GROWTH; CELL MATURATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ELECTRIC RESISTANCE; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM CELL; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; SURFACE CHARGE; TIGHT JUNCTION; BRONCHUS; CELL CULTURE; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; LUNG; METABOLISM; PHARMACOLOGY;

BRONCHI; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; CELL-FREE SYSTEM; CELLS, CULTURED; CHITOSAN; CULTURE MEDIA; EPITHELIAL CELLS; GOLD; HUMANS; LUNG; METAL NANOPARTICLES; OXIDANTS; REACTIVE OXYGEN SPECIES; SILVER;

EID: 84924907204     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/s12951-014-0062-4     Document Type: Article

References (73)

1. Taylor U, Barchanski A, Garrels W, Klein S, Kues W, Barcikowski S, et al. Toxicity of gold nanoparticles on somatic and reproductive cells. Adv Exp Med Biol. 2012;733:125-33.
2. Stoehr LC, Gonzalez E, Stampfl A, Casals E, Duschl A, Puntes V, et al. Shape matters: effects of silver nanospheres and wires on human alveolar epithelial cells. Part Fibre Toxicol. 2011;8:36.
3. Suresh AK, Pelletier DA, Wang W, Morrell-Falvey JL, Gu B, Doktycz MJ. Cytotoxicity induced by engineered silver nanocrystallites is dependent on surface coatings and cell types. Langmuir. 2012;28:2727-35.
4. Gerber A, Bundschuh M, Klingelhofer D, Groneberg DA. Gold nanoparticles: recent aspects for human toxicology. J Occup Med Toxicol. 2013;8:32.
5. Sharma VK, Yngard RA, Lin Y. Silver nanoparticles: green synthesis and their antimicrobial activities. Adv Colloid Interf Sci. 2009;145:83-96.
6. Bartlomiejczyk T, Lankoff A, Kruszewski M, Szumiel I. Silver nanoparticles - allies or adversaries? Ann Agric Environ Med. 2013;20:48-54.
7. Kruszewski M, Brzoska K, Brunborg G, Asare N, Dobrzynska M-g, Dusinska M, et al. Toxicity of silver nanomaterials in higher eukaryotes. Adv Mol Toxicol. 2011;5:179-218.
8. Jena P, Mohanty S, Mallick R, Jacob B, Sonawane A. Toxicity and antibacterial assessment of chitosan-coated silver nanoparticles on human pathogens and macrophage cells. Int J Nanomedicine. 2012;7:1805-18.
9. Hackenberg S, Scherzed A, Kessler M, Hummel S, Technau A, Froelich K, et al. Silver nanoparticles: evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. Toxicol Lett. 2011;201:27-33.
10. Ng CT, Li JJ, Gurung RL, Hande MP, Ong CN, Bay BH, et al. Toxicological profile of small airway epithelial cells exposed to gold nanoparticles. Exp Biol Med (Maywood). 2013;238:1355-61.
11. Pan Y, Wu Q, Liu R, Shao M, Pi J, Zhao X, et al. Inhibition effects of gold nanoparticles on proliferation and migration in hepatic carcinoma-conditioned HUVECs. Bioorg Med Chem Lett. 2014;24:679-84.
12. Tiedemann D, Taylor U, Rehbock C, Jakobi J, Klein S, Kues WA, et al. Reprotoxicity of gold, silver, and gold-silver alloy nanoparticles on mammalian gametes. Analyst. 2014;139:931-42.
13. Paul W, Shelma R, Sharma CP. Alginate Encapsulated Anacardic Acid-Chitosan Self Aggregated Nanoparticles for Intestinal Delivery of Protein Drugs. J Nanopharm Drug Deliv. 2013;1:82-91.
14. Limpeanchob N, Tiyaboonchai W, Lamlertthon S, Viyoch J, Jaipan S. Efficacy and Toxicity of Amphotericin B-Chitosan Nanoparticles in Mice with Induced Systemic Candidiasis. (Naresuan Univ J). 2013;14:27-34.
15. Tiyaboonchai W. Chitosan nanoparticles: a promising system for drug delivery. Naresuan Univ J. 2013;11:51-66.
16. Tabata Y, Ikada Y. Macrophage phagocytosis of biodegradable microspheres composed of lactic acid/glycolic acid homo-and copolymers. J Biomed Mater Res. 1988;22:837-58.
17. Ma Z, Lim TM, Lim L-Y. Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats. Int J Pharm. 2005;293:271-80.
18. Bowman K, Leong KW. Chitosan nanoparticles for oral drug and gene delivery. Int J Nanomedicine. 2006;1:117.
19. Garbuzenko OB, Winkler JS, Tomassone MS, Minko T. Biodegradable Janus Nanoparticles for Local Pulmonary Delivery of Hydrophilic and Hydrophobic Molecules to the Lungs. Langmuir. 2014;30(43):12941-9.
20. Guo X, Zhang X, Ye L, Zhang Y, Ding R, Hao Y, et al. Inhalable microspheres embedding chitosan-coated PLGA nanoparticles for 2-methoxyestradiol. J Drug Target. 2014;22:421-7.
21. Schrand AM, Rahman MF, Hussain SM, Schlager JJ, Smith DA, Ali SF. Metal-based nanoparticles and their toxicity assessment. Wires Nanomed Nanobi. 2010;2:544-68.
22. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311:622-7.
23. Foldbjerg R, Dang DA, Autrup H. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol. 2011;85:743-50.
24. Limbach LK, Wick P, Manser P, Grass RN, Bruinink A, Stark WJ. Exposure of engineered nanoparticles to human lung epithelial cells: influence of chemical composition and catalytic activity on oxidative stress. Environ Sci Technol. 2007;41:4158-63.
25. Pourova J, Kottova M, Voprsalova M, Pour M. Reactive oxygen and nitrogen species in normal physiological processes. Acta Physiol. 2010;198:15-35.
26. Monopoli MP, Pitek AS, Lynch I, Dawson KA. Formation and characterization of the nanoparticle-protein corona. Methods Mol Biol. 2013;1025:137-55.
27. Casals EPT, Duschl A, Oostingh GJ, Puntes V. Time evolution of the nanoparticle protein corona. Am Chem Soc. 2010;4:10.
28. Saptarshi SR, Duschl A, Lopata AL. Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J Nanobiotechnol. 2013;11:26.
29. Foucaud L, Wilson MR, Brown DM, Stone V. Measurement of reactive species production by nanoparticles prepared in biologically relevant media. Toxicol Lett. 2007;174:1-9.
30. Bouwmeester H, Lynch I, Marvin HJ, Dawson KA, Berges M, Braguer D, et al. Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology. 2011;5:1-11.
31. Bachand GD, Allen A, Bachand M, Achyuthan KE, Seagrave JC, Brozik SM. Cytotoxicity and inflammation in human alveolar epithelial cells following exposure to occupational levels of gold and silver nanoparticles. J Nanopart Res. 2012;14:1-10.
32. Politis M, Pilinis C, Lekkas T. Ultrafine particles (UFP) and health effects. Dangerous. Like no other PM? Review and analysis. Global NEST J. 2008;10:439-52.
33. Bakand S, Hayes A, Dechsakulthorn F. Nanoparticles: a review of particle toxicology following inhalation exposure. Inhal Toxicol. 2012;24:125-35.
34. Saieg MA, Cury PM, Godleski JJ, Stearns R, Duarte LG, D'Agostino L, et al. Differential elemental distribution of retained particles along the respiratory tract. Inhal Toxicol. 2011;23:459-67.
35. Löndahl J, Möller W, Pagels JH, Kreyling WG, Swietlicki E, Schmid O. Measurement techniques for respiratory tract deposition of airborne nanoparticles: A critical review. J Aerosol Med Pulm Drug Deliv. 2013.
36. Witschi HR, Last JA. Toxic responses of the respiratory system. Casarett and Doull's Toxicology: The basic science of poisons. New York: McGraw-Hill; 2001. p. 515-34.
37. Siegmann K, Scherrer L, Siegmann H. Physical and chemical properties of airborne nanoscale particles and how to measure the impact on human health. J Mol Struct THEOCHEM. 1998;458:191-201.
38. Lundborg M, Johard U, Låstbom L, Gerde P, Camner P. Human alveolar macrophage phagocytic function is impaired by aggregates of ultrafine carbon particles. Environ Res. 2001;86:244-53.
39. Blank F, Gehr P, Rothen-Rutishauser B. In vitro human lung cell culture models to study the toxic potential of nanoparticles. Nanotoxicity: From in vitro, in vivo models to health risks. Chichester, England: Wiley; 2009. p. 379-95.
40. Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005;113:823-39.
41. Muhlfeld C, Gehr P, Rothen-Rutishauser B. Translocation and cellular entering mechanisms of nanoparticles in the respiratory tract. Swiss Med Wkly. 2008;138:387.
42. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973;51:1417-23.
43. Albright CD, Jones RT, Hudson EA, Fontana JA, Trump BF, Resau JH. Transformed human bronchial epithelial cells (BEAS-2B) alter the growth and morphology of normal human bronchial epithelial cells in vitro. Cell Biol Toxicol. 1990;6:379-98.
44. Lechner J, LaVeck M. A serum-free method for culturing normal human bronchial epithelial cells at clonal density. J Tissue Cult Methods. 1985;9:43-8.
45. Lieber M, Todaro G, Smith B, Szakal A, Nelson-Rees W. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer. 1976;17:62-70.
46. Smith B. Cell line A549: a model system for the study of alveolar type II cell function. Am Rev Respir Dis. 1977;115:285-93.
47. AshaRani P, Low Kah Mun G, Hande MP, Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano. 2008;3:279-90.
48. Zhang H, Xia T, Meng H, Xue M, George S, Ji Z, et al. Differential expression of syndecan-1 mediates cationic nanoparticle toxicity in undifferentiated versus differentiated normal human bronchial epithelial cells. ACS Nano. 2011;5:2756-69.
49. Oostingh GJ, Schlickum S, Friedl P, Schon MP. Impaired induction of adhesion molecule expression in immortalized endothelial cells leads to functional defects in dynamic interactions with lymphocytes. J Investig Dermatol. 2007;127:2253-8.
50. Lin H, Li H, Cho HJ, Bian S, Roh HJ, Lee MK, et al. Air-liquid interface (ALI) culture of human bronchial epithelial cell monolayers as an in vitro model for airway drug transport studies. J Pharm Sci. 2007;96:341-50.
51. Qi L-F, Xu Z-R, Li Y, Jiang X, Han X-Y. In vitro effects of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cells. World J Gastroenterol. 2005;11:5136.
52. Hu Y-L, Qi W, Han F, Shao J-Z, Gao J-Q. Toxicity evaluation of biodegradable chitosan nanoparticles using a zebrafish embryo model. Int J Nanomedicine. 2011;6:3351-9.
53. Chen Z, Wang Z, Chen X, Xu H, Liu J. Chitosan-capped gold nanoparticles for selective and colorimetric sensing of heparin. J Nanopart Res. 2013;15:1-9.
54. Wei D, Qian W. Facile synthesis of Ag and Au nanoparticles utilizing chitosan as a mediator agent. Colloids Surf B: Biointerfaces. 2008;62:136-42.
55. Amidi M, Hennink WE. Chitosan-based formulations of drugs, imaging agents and biotherapeutics. Adv Drug Deliv Rev. 2010;62:1-2.
56. Ojea-Jiménez I, García-Fernández L, Lorenzo J, Puntes VF. Facile preparation of cationic gold nanoparticle-bioconjugates for cell penetration and nuclear targeting. ACS Nano. 2012;6:7692-702.
57. Ekstrand-Hammarstrom B, Akfur CM, Andersson PO, Lejon C, Osterlund L, Bucht A. Human primary bronchial epithelial cells respond differently to titanium dioxide nanoparticles than the lung epithelial cell lines A549 and BEAS-2B. Nanotoxicology. 2012;6:623-34.
58. Fleischer CC, Payne CK. Nanoparticle surface charge mediates the cellular receptors used by protein-nanoparticle complexes. J Phys Chem B. 2012;116:8901-7.
59. Izak-Nau E, Voetz M, Eiden S, Duschl A, Puntes VF. Altered characteristics of silica nanoparticles in bovine and human serum: the importance of nanomaterial characterization prior to its toxicological evaluation. Part Fibre Toxicol. 2013;10:56.
60. Marambio-Jones C, Hoek EM. A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res. 2010;12:1531-51.
61. Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett. 2008;582:1783-7.
62. Gaisberger M, Šanovic R, Dobias H, Kolarz P, Moder A, Thalhamer J, et al. Effects of ionized waterfall aerosol on pediatric allergic asthma. J Asthma. 2012;49:830-8.
63. Lenz A-G, Stoeger T, Cei D, Schmidmeir M, Pfister N, Burgstaller G, Lentner B, Eickelberg O, Meiners S, Schmid O: Efficient bioactive delivery of aerosolized drugs to human pulmonary epithelial cells cultured at air-liquid interface conditions. Am J Respir Cell Mol Biol 2014 526-535
64. Brown DM, Stone V, Findlay P, MacNee W, Donaldson K. Increased inflammation and intracellular calcium caused by ultrafine carbon black is independent of transition metals or other soluble components. Occup Environ Med. 2000;57:685-91.
65. Robinson JP, Bruner LH, Bassoe CF, Hudson JL, Ward PA, Phan SH. Measurement of intracellular fluorescence of human monocytes relative to oxidative metabolism. J Leukoc Biol. 1988;43:304-10.
66. Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Baldelli Bombelli F, et al. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc. 2011;133:2525-34.
67. Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes VF. Hardening of the Nanoparticle-Protein Corona in Metal (Au, Ag) and Oxide (Fe3O4, CoO, and CeO2) Nanoparticles. Small. 2011;7:3479-86.
68. Aschberger K, Johnston HJ, Stone V, Aitken RJ, Hankin SM, Peters SA, et al. Review of carbon nanotubes toxicity and exposure-appraisal of human health risk assessment based on open literature. Crit Rev Toxicol. 2010;40:759-90.
69. Li N, Xia T, Nel AE. The role of oxidative stress in ambient particulate matter-induced lung diseases and its implications in the toxicity of engineered nanoparticles. Free Radic Biol Med. 2008;44:1689-99.
70. Stone V, Donaldson K. Nanotoxicology: signs of stress. Nat Nanotechnol. 2006;1:23-4.
71. Weissenberg A, Sydlik U, Peuschel H, Schroeder P, Schneider M, Schins RP, et al. Reactive oxygen species as mediators of membrane-dependent signaling induced by ultrafine particles. Free Radic Biol Med. 2010;49:597-605.
72. Turkevich J, Stevenson PC, Hillier J. A study of the nucleation and growth processes in the synthesis of colloidal gold. Discussions of the Faraday Society. 1952;11:55-75.
73. Jana NR, Gearheart L, Murphy CJ. Seeding Growth for Size Control of 5-40 nm Diameter Gold Nanoparticles. Langmuir. 2001;17:6782-6786.